{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:25:48Z","timestamp":1792898748711,"version":"4.5.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100009210","name":"Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006229","name":"Oak Ridge Institute for Science and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006229","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Human noroviruses are the most common viral agents of acute gastroenteritis. Recently, human intestinal enteroids were shown to be permissive for norovirus infection. We tested their suitability as a system to study norovirus neutralization. Hyperimmune sera raised against virus-like particles (VLPs) representing different genotypes showed highly specific neutralization activity against GII.4 and GII.6 noroviruses. Carbohydrate blocking assays and neutralization exhibited similar patterns in antibody responses. Notably, sera produced against chimeric VLPs that presented swapped structural shell and protruding (P) domains, from different genotypes showed that neutralization is primarily mediated by antibodies mapping to the P domain of the norovirus capsid protein. This study provides empirical information on the antigenic differences among genotypes as measured by neutralization, which could guide vaccine design.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa116","type":"journal-article","created":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T05:00:35Z","timestamp":1584075635000},"page":"1205-1214","source":"Crossref","is-referenced-by-count":43,"title":["Genotype-Specific Neutralization of Norovirus Is Mediated by Antibodies Against the Protruding Domain of the Major Capsid Protein"],"prefix":"10.1093","volume":"225","author":[{"given":"Lauren A","family":"Ford-Siltz","sequence":"first","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Wales","sequence":"additional","affiliation":[{"name":"Center for Food Safety and Applied Nutrition, Food and Drug Administration, Laurel, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Tohma","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamei","family":"Gao","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-4740","authenticated-orcid":false,"given":"Gabriel I","family":"Parra","sequence":"additional","affiliation":[{"name":"Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"2022040118031058900_CIT0001","doi-asserted-by":"crossref","first-page":"e0142927","DOI":"10.1371\/journal.pone.0142927","article-title":"Aetiology-specific estimates of the global and regional incidence and mortality of diarrhoeal diseases commonly transmitted through food","volume":"10","author":"Pires","year":"2015","journal-title":"PLoS One"},{"key":"2022040118031058900_CIT0002","doi-asserted-by":"crossref","first-page":"e0151219","DOI":"10.1371\/journal.pone.0151219","article-title":"Global economic burden of norovirus gastroenteritis","volume":"11","author":"Bartsch","year":"2016","journal-title":"PLoS One"},{"key":"2022040118031058900_CIT0003","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J Gen Virol"},{"key":"2022040118031058900_CIT0004","doi-asserted-by":"crossref","first-page":"e1006136","DOI":"10.1371\/journal.ppat.1006136","article-title":"Static and evolving norovirus genotypes: implications for epidemiology and immunity","volume":"13","author":"Parra","year":"2017","journal-title":"PLoS Pathog"},{"key":"2022040118031058900_CIT0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/infdis\/jiu496","article-title":"Impact of genotype-specific herd immunity on the circulatory dynamism of norovirus: a 10-year longitudinal study of viral acute gastroenteritis","volume":"211","author":"Sakon","year":"2015","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/cid\/cit763","article-title":"Multiple norovirus infections in a birth cohort in a Peruvian periurban community","volume":"58","author":"Saito","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2022040118031058900_CIT0007","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3201\/eid2006.131627","article-title":"Sequential gastroenteritis episodes caused by 2 norovirus genotypes","volume":"20","author":"Parra","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022040118031058900_CIT0008","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/jcm.31.8.2185-2191.1993","article-title":"Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations","volume":"31","author":"Green","year":"1993","journal-title":"J Clin Microbiol"},{"key":"2022040118031058900_CIT0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"2022040118031058900_CIT0010","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.0803275105","article-title":"Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus","volume":"105","author":"Choi","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022040118031058900_CIT0011","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1086\/427779","article-title":"Association of histo-blood group antigens and susceptibility to norovirus infections","volume":"191","author":"Rockx","year":"2005","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0012","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N Engl J Med"},{"key":"2022040118031058900_CIT0013","doi-asserted-by":"crossref","first-page":"e1005334","DOI":"10.1371\/journal.ppat.1005334","article-title":"Correlates of protection against norovirus infection and disease-where are we now, where do we go?","volume":"12","author":"Ramani","year":"2016","journal-title":"PLoS Pathog"},{"key":"2022040118031058900_CIT0014","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological correlates of protection against a GII.4 norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"2022040118031058900_CIT0016","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"2022040118031058900_CIT0017","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3201\/eid2408.180126","article-title":"Human norovirus replication in human intestinal enteroids as model to evaluate virus inactivation","volume":"24","author":"Costantini","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2022040118031058900_CIT0018","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/7651_2017_1","article-title":"Human intestinal enteroids: new models to study gastrointestinal virus infections","volume":"1576","author":"Zou","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2022040118031058900_CIT0019","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1128\/JVI.06729-11","article-title":"Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens","volume":"86","author":"Parra","year":"2012","journal-title":"J Virol"},{"key":"2022040118031058900_CIT0020","doi-asserted-by":"crossref","first-page":"e0133665","DOI":"10.1371\/journal.pone.0133665","article-title":"Llama nanoantibodies with therapeutic potential against human norovirus diarrhea","volume":"10","author":"Garaicoechea","year":"2015","journal-title":"PLoS One"},{"key":"2022040118031058900_CIT0021","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2017.00073","article-title":"Characterization of the genomic diversity of norovirus in linked patients using a metagenomic deep sequencing approach","volume":"8","author":"Nasheri","year":"2017","journal-title":"Front Microbiol"},{"key":"2022040118031058900_CIT0022","doi-asserted-by":"crossref","first-page":"e01211-16","DOI":"10.1128\/genomeA.01211-16","article-title":"Complete genome sequence of human norovirus strain GII.P7-GII.6 detected in a patient in the United States in 2014","volume":"4","author":"Yang","year":"2016","journal-title":"Genome Announc"},{"key":"2022040118031058900_CIT0023","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jviromet.2016.03.013","article-title":"Optimizing a custom tiling microarray for low input detection and identification of unamplified virus targets","volume":"234","author":"Yu","year":"2016","journal-title":"J Virol Methods"},{"key":"2022040118031058900_CIT0024","doi-asserted-by":"crossref","first-page":"e00095-18","DOI":"10.1128\/genomeA.00095-18","article-title":"Complete genome sequence of a nontypeable GII norovirus detected in Peru","volume":"6","author":"Tohma","year":"2018","journal-title":"Genome Announc"},{"key":"2022040118031058900_CIT0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygeno.2017.01.002","article-title":"HIVE-heptagon: a sensible variant-calling algorithm with post-alignment quality controls","volume":"109","author":"Simonyan","year":"2017","journal-title":"Genomics"},{"key":"2022040118031058900_CIT0026","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: elegant graphics for data analysis","author":"Wickham","year":"2009"},{"key":"2022040118031058900_CIT0027","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/molbev\/msm092","article-title":"MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0","volume":"24","author":"Tamura","year":"2007","journal-title":"Mol Biol Evol"},{"key":"2022040118031058900_CIT0028","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"2022040118031058900_CIT0029","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/infdis\/jiz170","article-title":"Persistence of antibodies to 2 virus-like particle norovirus vaccine candidate formulations in healthy adults: 1-year follow-up with memory probe vaccination","volume":"220","author":"Atmar","year":"2019","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0030","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1128\/JCM.00865-17","article-title":"Characterization of antigenic relatedness between GII.4 and GII.17 noroviruses by use of serum samples from norovirus-infected patients","volume":"55","author":"Dai","year":"2017","journal-title":"J Clin Microbiol"},{"key":"2022040118031058900_CIT0031","doi-asserted-by":"crossref","first-page":"e67592","DOI":"10.1371\/journal.pone.0067592","article-title":"Identification of a broadly cross-reactive epitope in the inner shell of the norovirus capsid","volume":"8","author":"Parra","year":"2013","journal-title":"PLoS One"},{"key":"2022040118031058900_CIT0032","doi-asserted-by":"crossref","first-page":"e02202-19","DOI":"10.1128\/mBio.02202-19","article-title":"Population genomics of GII.4 noroviruses reveal complex diversification and new antigenic sites involved in the emergence of pandemic strains","volume":"10","author":"Tohma","year":"2019","journal-title":"MBio"},{"key":"2022040118031058900_CIT0033","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2018.08.039","article-title":"Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses","volume":"155","author":"Alvarado","year":"2018","journal-title":"Gastroenterology"},{"key":"2022040118031058900_CIT0034","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nri.2017.106","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"2022040118031058900_CIT0035","first-page":"5","article-title":"Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development","volume":"18","author":"Hoshino","year":"2000","journal-title":"J Health Popul Nutr"},{"key":"2022040118031058900_CIT0036","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2010.05829.x","article-title":"Structural basis of influenza virus neutralization","volume":"1217","author":"Han","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"2022040118031058900_CIT0037","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1586\/14760584.2015.1001750","article-title":"Polio endgame: the global introduction of inactivated polio vaccine","volume":"14","author":"Patel","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"2022040118031058900_CIT0038","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"2022040118031058900_CIT0039","doi-asserted-by":"crossref","first-page":"e121077","DOI":"10.1172\/jci.insight.121077","article-title":"Safety and immunogenicity of an oral tablet norovirus vaccine, a phase I randomized, placebo-controlled trial","volume":"3","author":"Kim","year":"2018","journal-title":"JCI Insight"},{"key":"2022040118031058900_CIT0040","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/infdis\/jiu497","article-title":"Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults","volume":"211","author":"Bernstein","year":"2015","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0041","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1086\/605127","article-title":"Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001\u20132007","volume":"200","author":"Siebenga","year":"2009","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0042","doi-asserted-by":"crossref","first-page":"10061","DOI":"10.1038\/ncomms10061","article-title":"Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014","volume":"6","author":"Chan","year":"2015","journal-title":"Nat Commun"},{"key":"2022040118031058900_CIT0043","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3201\/eid2307.170034","article-title":"Norovirus GII.P16\/GII.2-associated gastroenteritis, China, 2016","volume":"23","author":"Ao","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2022040118031058900_CIT0044","doi-asserted-by":"crossref","first-page":"e1002705","DOI":"10.1371\/journal.ppat.1002705","article-title":"Immunogenetic mechanisms driving norovirus GII.4 antigenic variation","volume":"8","author":"Lindesmith","year":"2012","journal-title":"PLoS Pathog"},{"key":"2022040118031058900_CIT0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/infdis\/129.6.709","article-title":"Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers","volume":"129","author":"Wyatt","year":"1974","journal-title":"J Infect Dis"},{"key":"2022040118031058900_CIT0046","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jcv.2008.08.001","article-title":"Calicivirus shedding in children after recovery from diarrhoeal disease","volume":"43","author":"Kirkwood","year":"2008","journal-title":"J Clin Virol"},{"key":"2022040118031058900_CIT0047","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1007\/s00431-015-2591-8","article-title":"Multiple consecutive norovirus infections in the first 2 years of life","volume":"174","author":"Blazevic","year":"2015","journal-title":"Eur J Pediatr"},{"key":"2022040118031058900_CIT0048","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1371\/journal.pmed.0050031","article-title":"Mechanisms of GII.4 norovirus persistence in human populations","volume":"5","author":"Lindesmith","year":"2008","journal-title":"PLoS Med"},{"key":"2022040118031058900_CIT0049","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.immuni.2019.05.007","article-title":"Sera antibody repertoire analyses reveal mechanisms of broad and pandemic strain neutralizing responses after human norovirus vaccination","volume":"50","author":"Lindesmith","year":"2019","journal-title":"Immunity"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaa116\/33023861\/jiaa116.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/7\/1205\/43230152\/jiaa116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/225\/7\/1205\/43230152\/jiaa116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:10:17Z","timestamp":1648836617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/225\/7\/1205\/5807957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":49,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,3,17]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa116","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2020,3,17]]}}}